Objective/Background: Although a number of studies have considered the effects of reminiscence therapy, none have examined whether a therapy that combines reminiscence with productive activity has a beneficial effect on elderly dementia patients. This study tests our hypothesis that productive activities with reminiscence in occupational therapy (PAROT) can alleviate depressive symptoms and improve task performance of elderly dementia patients. Methods: Thirty-six patients with dementia were randomly divided into two groups, namely, an intervention group (n Z 17) and a control group (n Z 19). The intervention group had six activity sessions (making rice balls and cakes; one session/week) while reminiscing about the activity. Measurements were performed using the Cornell Scale for Depression in Dementia (CSDD), Multidimensional Observation Scale for Elderly Subjects (MOSES), Vitality Index, and Mini-Mental State Examination (MMSE). The performance of the patients was assessed based on photographs of the products after the first and sixth sessions. Results: Six patients dropped out while the study was in progress, thus leaving 15 patients in the intervention group and 15 patients in the control group. The scores of depression symptoms in CSDD and MOSES were significantly improved for the intervention group, while within-group comparison showed no significant differences in CSDD, MOSES, or MMSE total scores. In terms of task performance, 88% of the patients in the intervention group, including two patients with severe dementia, showed significant improvement in making the product.

The results suggested that the subject-chosen activities in occupational therapy could improve the psychiatric symptoms, suspiciousness, and preoccupation of the inpatients with chronic schizophrenia.

The results suggest that early occupational therapy may improve functional independence in patients with acute schizophrenia.

Aim:The aim of this study was to develop a new Brief Scale of Self-rated Health Condition with Acute Schizophrenia (BsHAS) and to examine its reliability, validity and correlation to psychiatric symptoms. Methods:We examined the reliability and validity of the BsHAS consisting of four items (physical health condition, mood, interpersonal fatigue and interest) for 199 inpatients with acute schizophrenia and compared the patients' subjective health conditions as assessed by the BsHAS with their objective psychiatric symptoms.Results: Cronbach's α coefficient was 0.79, indicating that the reliability of the scale was sufficient. These four items chosen from the previous studies were approved by an expert panel, which suggested that the scale has content validity. The BsHAS total score was significantly improved at discharge. However, the effect size was only −0.24. In particular, improvement was not recognized in the interpersonal fatigue item. These findings suggest that some patients were discharged without realizing the improvement of their health condition. The patients answered all questions without subsequently showing deteriorating symptoms, suggesting that the scale can be applied to acute-phase patients with schizophrenia. No obvious relation was recognized between the patients' subjective health condition as assessed by the BsHAS and their objective psychiatric symptoms. This result suggests that the BsHAS can provide additional information to the objective assessment of psychiatric symptoms. Conclusion:These results show that the BsHAS can help psychiatric professionals to know patients' subjective health conditions, and that the longitudinal use of this scale may be useful for evaluating the degree of recovery from schizophrenia.

IntroductionThe application of advanced technologies in paediatric rehabilitation to improve performance and enhance everyday functioning shows considerable promise. The aims of this systematic review are to investigate the effectiveness of robotic-assisted therapy for upper extremity function in children and adolescents with cerebral palsy and to extend the scope of intervention from empirical evidence.Methods and analysisMultiple databases, including MEDLINE (Ovid), PubMed, CINAHL, Scopus, Web of Science, Cochrane Library and IEEE Xplore, will be comprehensively searched for relevant randomised controlled trials and non-randomised studies. The grey literature will be accessed on the ProQuest Dissertations & Theses Global database, and a hand search from reference lists of previous articles will be performed. The papers written in English language will be considered, with no limitation on publication date. Two independent reviewers will identify eligible studies, evaluate the level of evidence (the Oxford Centre for Evidence-Based Medicine) and appraise methodological quality and risk of bias (the Standard quality assessment criteria for evaluating primary research papers from a variety of fields (QualSyst tool); the Grading of Recommendations Assessment, Development and Evaluation). Data will be appropriately extracted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. A narrative synthesis will be provided to summarise the results, and a meta-analysis will be conducted if there is sufficient homogeneity across outcomes.PROSPERO registration numberCRD42020205818.Ethics and disseminationEthical approval is not required for this study. The findings will be disseminated via a peer-reviewed journal and international conferences.